Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04362137 |
|---|---|
| Brief Title: | Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) (RUXCOVID) |
| First Submitted : | April 22, 2020 |
| First Submitted that Met QC Criteria : | April 22, 2020 |
| First Posted : | April 24, 2020 |
| Last Update Submitted that Met QC Criteria : | November 10, 2020 |
| Last Update Posted : | November 12, 2020 |